ScreenPoint Medical

🦃 Happy Thanksgiving! 🍂 We’re thankful this season to host radiology LEGENDS Dr. Solveig Hofvind, Dr. Brem Rachel, and Dr. Roger Yang, MD, FACR at our booth during #RSNA! Catch them at Booth 5316 in the RSNA South Hall as part of our Insights Series. ✨ Connect with experts driving innovation in research, practice, and business! 📅 Details below... Still haven't booked your 15 min demo with us? Make yours now via our website! bit.ly/3YBGDAx See you there! #Radiology #HealthAI

Connecting with global leaders in #radiology and diving into WORKFLOW, CONFIDENCE, RESULTS by #Transpara that can support your practice! ( 🩷👟Oh, and new pink kicks...) This was #RSNA 2023! A huge THANK YOU to everyone who visited our booth, or simply stopped by to chat 💗 Your insights, questions, and feedback drive us to think bigger and improve every day. We're now gearing up for RSNA 2024 - and we CAN'T WAIT to show you what's next… But until then… here's a look back at some of our favorite moments from last year! Don't forget to book a 15 minute demo with us at our booth! bit.ly/3YBGDAx

🔥 TRANSPARA 2.1 ALGORITHM AND TEMPORAL COMPARISON READY FOR #RSNA 2024! 🔥 🌟 #Transpara 2.1 – Top Decile Performance ✅ An algorithm achieving sensitivity and specificity comparable to the top 10% of radiologists 🌟 Transpara Temporal Comparison ✅ Evaluate regions with 3 priors and up to 6 years of mammograms FDA cleared. Workflow just got faster, and priors, simpler. 👋 Come see us at booth 5316 to learn more! #BreastAI #HealthAI KIMBERLY GREENE Ad-Jan Bos Meri Jane Smith, MBA Dana Ahrold JON PAUL C. Kerri Waldren R.T. (R)(M) Tiffany Benoit-Smith

Can #AI help radiologists improve cancer detection in women with dense breasts? Learn more about University Radiology's experience as Dr. Roger Yang presents real world clinical evidence on #Transpara performance in screening tomosynthesis for dense and non-dense breasts. Details below and see you there! #RSNA

🗣 That one CRUCIAL but often OVERLOOKED factor in evaluating breast AI for screening? Testing on representative, real-world screening populations, not just cancer-enriched datasets. A recent study by Plimpton et al. at UCLA sheds light on this gap. bit.ly/3APTAz6 Consistent with findings across 35+ peer-reviewed studies, this new research shows that Transpara can detect cancers missed at the time of screening. AND? 🔥 Transpara achieves this across a diverse U.S. screening population, in both FFDM and DBT settings 🔥 Our take? We believe real-world evidence matters, and it's exciting to see #Transpara deliver enhanced workflow, confidence, and results... REGARDLESS of patient background. Let’s have a chat about it at #RSNA? #ClinicalResearch #HealthAI

🔥 FRESH FROM UCLA: NEW STUDY ALERT 🔥 A recent paper by Plimpton et al. at UCLA confirms what we’ve been pushing for: Transpara’s faster reads and boosted accuracy in detecting cancer, in real-world screening populations and dense breasts. ⏭ The results? 🔼 #Transpara caught cancers missed by radiologists, a median time of 272 days (FFDM) and 248 days (DBT) sooner than symptoms brought the woman back to her provider. 🔼 Most of these cases were in women with BIRADS C or D. 🔼 Detected 54% of false negatives (7/13) in FFDM and 40% in DBT (4/10) that radiologists missed. Read faster? ✅ Read more accurately? ✅ Read better in the hardest images? ✅ See you at #RSNA 2024? bit.ly/3YBGDAx #HealthAI #BreastAI

📣How can computer-aided detection software as an independent third reader impact detection rates and streamline the German breast cancer screening program? Hear Dr. Thomas Lehnen, MD, discuss this at #RSNA 2024, featuring #Transpara. ⏭ Details below. Join us there?

How can #AI prioritize interpretation to reduce turnaround time in breast cancer detection and diagnosis? Dr. Gopal Rathnam Vijayaraghavan, MD, MPH will be presenting at #RSNA 2024, featuring #Transpara. Want a better workflow for your practice? Join the talk... details below!

Let's talk better worfklow, confidence and results for your clinical practice at RSNA 2024. Book your demo today bit.ly/3YBGDAx See you there! KIMBERLY GREENE Meri Jane Smith, MBA Dana Ahrold Jon Paul Castorena Kerri Waldren R.T. (R)(M)

It's 3:30PM and you're reading your 42nd screening mammogram. Here's a BI-RADS D to read. Can you do it faster without any compromise on reading confidence? Join us at RSNA 2024 and we'll talk about how Transpara brings you better workflow, confidence and workflow. See why 25% of top hospitals in the US use #Transpara. Book a demo via our website today. bit.ly/3YBGDAx KIMBERLY GREENE Ad-Jan Bos Meri Jane Smith, MBA Dana Ahrold Jon Paul C. Kerri Waldren Tiffany Benoit-Smith #RSNA #HealthAI